Advertisement

Plasma homocysteine, vitamin B12 and folate levels in age-related macular degeneration

  • Gunhal Kamburoglu
  • Koray Gumus
  • Sibel Kadayıfcılar
  • Bora Eldem
Clinical Investigation

Abstract

Purpose

The purpose of this study was to investigate the association of age-related macular degeneration (AMD) with plasma homocysteine, vitamin B12, and folate levels.

Methods

Sixty patients diagnosed with AMD at our clinic between March 2004 and September 2004 were assessed in a prospective cross-sectional study. Plasma homocysteine, vitamin B12, and folate levels taken after 8 h of fasting from 30 patients with exudative AMD and 30 patients with dry AMD were compared with the results of 30 age- and sex-matched healthy participants.

Results

Patients with both exudative and dry types of AMD had significantly higher plasma homocysteine levels (mean 14.19±3.11 μmol/l; 13.07±2.90 μmol/l respectively) compared with the controls (mean 10.79±2.56 μmol/l; (p=0.000 and p=0.008 respectively). Homocysteine levels were higher in the exudative AMD group compared with the dry AMD group, but the difference was not statistically significant (p=0.290). Plasma vitamin B12 levels were found to be significantly lower in the exudative AMD group (289.14±113.44 pg/l) compared with the controls (436.17±204.12 pg/l) and dry AMD group (443.47±190.83 pg/l; (p=0.000). Plasma folate levels were comparable among groups (p=0.106).

Conclusion

This study suggests an association between elevated plasma homocysteine and AMD regardless of the subtype. Further controlled prospective studies are needed to investigate the possible role of homocysteine in AMD and the effect of vitamin B12 and folate supplementation in this process.

Keywords

Age-related macular degeneration Homocysteine Vitamin B12 Folate 

Notes

Acknowledgements

The authors thank Osman Saracbası, PhD (Associate Professor of Biostatistics), for providing statistical assistance.

Reference

  1. 1.
    Anderson DH, Mullins RF, Hageman GS, Johnson LV (2002) A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134:411–431CrossRefPubMedGoogle Scholar
  2. 2.
    Archer DB, Garnier TA (1981) Electron microscopic features of experimental choroidal neovascularisation. Am J Ophthalmol 91:433–457PubMedGoogle Scholar
  3. 3.
    Ashfield-Watt PA, Moat SJ, Doshi SN, McDowell IF (2001) Folate, homocysteine, endothelial function and cardiovascular disease. What is the link? Biomed Pharmacother 55:425–433CrossRefPubMedGoogle Scholar
  4. 4.
    Attebo K, Mitchell P, Smith W (1996) Visual acuity and the cause of visual loss in Australia: the Blue Mountain Eye Study. Ophthalmology 103:357–364PubMedGoogle Scholar
  5. 5.
    Axer-Siegel R, Bourla D, Ehrlich R, Dotan G, Benjamini Y, Gavendo S, Weinberger D, Sela B (2004) Association of neovascular age-related macular degeneration and hyperhomocysteinemia. Am J Ophthalmol 137:84–89CrossRefPubMedGoogle Scholar
  6. 6.
    Campochiaro PA (2000) Retinal and choroidal neovascularization. J Cell Physiol 184:301–310CrossRefPubMedGoogle Scholar
  7. 7.
    Chiang PK, Gordon RK, Tal J, Zeng GC, Doctor BP, Pardhasaradhi K, McCann PP (1996) S-Adenosylmethionine and methylation. FASEB J 10:471–480PubMedGoogle Scholar
  8. 8.
    Coral K, Raman R, Rathi S, Rajesh M, Sulochana KN, Angayarkanni N, Paul PG, Ramakrishnan S (2005) Plasma homocysteine and total thiol content in patients with exudative age-related macular degeneration. Eye advanced on line publication, Apr 1,  http://dx.doi.org/10.1038/sj.eye.6701853
  9. 9.
    Friedman E (2000) The role of atherosclerotic processes in the pathogenesis of age related macular degeneration. Am J Ophthalmol 130:658–663CrossRefPubMedGoogle Scholar
  10. 10.
    Friedman E, Krupsky S, Lane AM, Oak SS, Friedman ES, Egan K, Gragoudas ES (1995) Ocular blood flow velocity in age related macular degeneration. Ophthalmology 102:640–646PubMedGoogle Scholar
  11. 11.
    Gao W, Jiang N, Meng Z, Tang J (1999) Hyperhomocysteinemia and hyperlipidemia in coronary heart disease. Chin Med J (Engl) 112:586–589Google Scholar
  12. 12.
    Grunwald JE, Hariprasad SM, DuPont J, Maguire MG, Fine SL, Brucker AJ, Maguire AM, Ho AC (1998) Foveolar choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci 39:385–390PubMedGoogle Scholar
  13. 13.
    Harpel PC, Zhang X, Borth W (1996) Homocysteine and homeostasis: pathogenetic mechanisms predisposing to thrombosis. J Nutr 126:1285–1289Google Scholar
  14. 14.
    Heuberger RA, Fisher AI, Jacques PF, Klein R, Klein BEK, Patla M, Mares-Perlman JA (2002) Relation of blood homocysteine and its nutritional determinants to age-related maculopathy in the third National Health and Nutrition Examination Survey. Am J Clin Nutr 76:897–902PubMedGoogle Scholar
  15. 15.
    Killingsworth MC, Sarks JP, Sarks SH (1990) Macrophage related to Bruch's membrane in age related macular degeneration. Eye 4:613–621PubMedGoogle Scholar
  16. 16.
    Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT (1998) Age specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 116:653–658PubMedGoogle Scholar
  17. 17.
    Lip PL, Blann AD, Hope-Ross M, Gibson JM, Lip GY (2001) Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. Ophthalmology 108:705–710CrossRefPubMedGoogle Scholar
  18. 18.
    Malinow MR, Bostom AG, Krauss RM (1999) Homocysteine, diet and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 99:178–182PubMedGoogle Scholar
  19. 19.
    Martin SC, Rauz S, Marr JE, Martin N, Jones AF, Dodson PM (2000) Plasma total homocysteine and retinal vascular disease. Eye 14:590–593PubMedGoogle Scholar
  20. 20.
    Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland M, Kvale G (1995) Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study. JAMA 274:1526–1533CrossRefPubMedGoogle Scholar
  21. 21.
    Parnetti L, Caso V, Amici S, Lanari A, Gallai V, Bottiglieri T (2002) Hyperhomocyst(e)inemia: a risk factor for cerebrovascular disease. Clin Exp Hypertens 24:501–509CrossRefPubMedGoogle Scholar
  22. 22.
    Perry DJ (1999) Hyperhomocysteinemia. Baillieres Best Pract Res Clin Haematol 12:451–477PubMedCrossRefGoogle Scholar
  23. 23.
    Rees MM, Rodgers GM (1993) Homocysteinemia: association of metabolic disorder with vascular disease and thrombosis. Thromb Res 71:337–359CrossRefPubMedGoogle Scholar
  24. 24.
    Sakurai E, Taguchi H, Anand A, Ambati BK, Gragoudas ES, Miller JW, Adamis AP, Ambati J (2003) Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci 44:2743–2749CrossRefPubMedGoogle Scholar
  25. 25.
    Selhub J, Miller JW (1992) The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 55:131–138PubMedGoogle Scholar
  26. 26.
    Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693–2698CrossRefPubMedGoogle Scholar
  27. 27.
    Stanger O, Weger M, Renner W, Konetschny R (2001) Vascular dysfunction in hyperhomocysteinemia. Implications for atherothrombotic disease. Clin Chem Lab Med 39:725–733CrossRefPubMedGoogle Scholar
  28. 28.
    Vine AK (2000) Hyperhomocysteinemia: a risk factor for central retinal vein occlusion. Am J Ophthalmol 129:640–644CrossRefPubMedGoogle Scholar
  29. 29.
    Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE, de Jong PT (1995) Age related macular degeneration is associated with atherosclerosis: the Rotterdam Study. Am J Epidemiol 142:404–409PubMedGoogle Scholar
  30. 30.
    Weger M, Stanger O, Deutschmann H, Temmel W, Renner W, Schmut O, Semmelrock J, Haas A (2002) Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central vein occlusion. Graefes Arch Clin Exp Ophthalmol 240:286–290CrossRefPubMedGoogle Scholar
  31. 31.
    Yıldırım C, Yaylalı V, Tatlıpınar S, Kaptanoğlu B, Akpınar S (2004) Hyperhomocysteinemia: a risk factor for retinal vein occlusion. Ophthalmologica 218:102–106CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Gunhal Kamburoglu
    • 1
  • Koray Gumus
    • 1
  • Sibel Kadayıfcılar
    • 1
  • Bora Eldem
    • 1
  1. 1.Department of OphthalmologyHacettepe University HospitalSıhhiye, AnkaraTurkey

Personalised recommendations